- Home
- BBIO vs PRMB Comparison
BBIO vs PRMB Comparison
Compare BBIO & PRMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- PRMB
- Stock Information
- Founded
- BBIO 2015
- PRMB 1955
- Country
- BBIO United States
- PRMB United States
- Employees
- BBIO N/A
- PRMB N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- PRMB
- Sector
- BBIO Health Care
- PRMB
- Exchange
- BBIO Nasdaq
- PRMB Nasdaq
- Market Cap
- BBIO 9.4B
- PRMB 10.7B
- IPO Year
- BBIO 2019
- PRMB N/A
- Fundamental
- Price
- BBIO $51.21
- PRMB $24.03
- Analyst Decision
- BBIO Strong Buy
- PRMB Strong Buy
- Analyst Count
- BBIO 16
- PRMB 11
- Target Price
- BBIO $64.44
- PRMB $38.64
- AVG Volume (30 Days)
- BBIO 2.2M
- PRMB 4.6M
- Earning Date
- BBIO 11-11-2025
- PRMB 08-07-2025
- Dividend Yield
- BBIO N/A
- PRMB 1.66%
- EPS Growth
- BBIO N/A
- PRMB N/A
- EPS
- BBIO N/A
- PRMB N/A
- Revenue
- BBIO $235,812,000.00
- PRMB $6,046,100,000.00
- Revenue This Year
- BBIO $115.49
- PRMB $33.90
- Revenue Next Year
- BBIO $64.61
- PRMB $3.75
- P/E Ratio
- BBIO N/A
- PRMB N/A
- Revenue Growth
- BBIO 7.62
- PRMB 26.25
- 52 Week Low
- BBIO $21.72
- PRMB $22.64
- 52 Week High
- BBIO $54.60
- PRMB $35.85
- Technical
- Relative Strength Index (RSI)
- BBIO 52.92
- PRMB 34.80
- Support Level
- BBIO $52.20
- PRMB $24.28
- Resistance Level
- BBIO $54.60
- PRMB $25.32
- Average True Range (ATR)
- BBIO 2.26
- PRMB 0.56
- MACD
- BBIO -0.06
- PRMB 0.05
- Stochastic Oscillator
- BBIO 56.48
- PRMB 4.24
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About PRMB Primo Brands Corporation Class A Common Stock
Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.